Home/Recalls/FDA-D-0659-2026
FDA DrugsClass II

Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Di...

Published: July 8, 2026Recall ID: D-0659-2026Category: drugsCountry: US

Reason for Recall / Hazard

Lack of Assurance of Sterility

Product Description & Identification

Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 85766-187-01.

Additional Source Details

FieldValue
CityTorrance
StateCA
Openfda › UniiEC2CNF7XFP
Openfda › Route › 1EPIDURAL
Openfda › Route › 2INFILTRATION
Openfda › Route › 3INTRACAUDAL
Openfda › Route › 4PERINEURAL
Openfda › Rxcui1737566
Openfda › Spl id4d6e159a-1dbb-c957-e063-6394a90aa5f7
Openfda › Brand nameLIDOCAINE HYDROCHLORIDE
Openfda › Spl set iddef640dd-bce2-4c18-9ee1-4a1cd5852e89
Openfda › Package ndc › 185766-187-01
Openfda › Package ndc › 285766-187-25
Openfda › Product ndc85766-187
Openfda › Generic nameLIDOCAINE HYDROCHLORIDE ANHYDROUS
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Substance nameLIDOCAINE HYDROCHLORIDE ANHYDROUS
Openfda › Manufacturer nameSportpharm LLC
Openfda › Application numberANDA208017
Openfda › Original packager product ndc65282-1605
Event id99204
Address 1379 Van Ness Ave Ste 1403
Address 2N/A
Code infoLot #: AE3102, 031926L01, 032026A01, Exp 11/30/2026; AE5052, 052026G01, Exp 04/30/2028.
Postal code90501-7211
Report date20260708
Product typeDrugs
Product quantityN/A
Reason for recallLack of Assurance of Sterility
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260608
Initial firm notificationTwo or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date20260702

Overview

  • Recalling FirmAsclemed USA Inc.
  • StatusOngoing
  • Risk LevelClass II
  • DistributionUSA Nationwide
Official Agency Alert